These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34433756)

  • 1. Inhibitory effect of traditional herbal (kampo) medicines on the replication of human parainfluenza virus type 2 in vitro.
    Uematsu J; Yamamoto H; Kihira S; Sakai-Sugino K; Ishiyama Y; Chindoh M; Baba A; Kazuta R; Hasegawa T; Fujimoto K; Funauchi A; Itoh A; Ookohchi A; Satoh S; Maeda Y; Kawano M; Tsurudome M; Nishio M; Hirai K; O'Brien M; Komada H
    Drug Discov Ther; 2021 Sep; 15(4):180-188. PubMed ID: 34433756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of kaempferol, quercetin and luteolin on the replication of human parainfluenza virus type 2 in vitro.
    Sakai-Sugino K; Uematsu J; Yamamoto H; Kihira S; Kawano M; Nishio M; Tsurudome M; Sekijima H; O'Brien M; Komada H
    Drug Discov Ther; 2024 Mar; 18(1):16-23. PubMed ID: 38382931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin inhibits human parainfluenza virus type 2 replication by the inhibition of genome RNA, mRNA and protein syntheses.
    Sakai-Sugino K; Uematsu J; Kamada M; Taniguchi H; Suzuki S; Yoshimi Y; Kihira S; Yamamoto H; Kawano M; Tsurudome M; O'Brien M; Itoh M; Komada H
    Drug Discov Ther; 2017 Nov; 11(5):246-252. PubMed ID: 29070744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosine.
    Uematsu J; Sakai-Sugino K; Kihira-Nakanishi S; Yamamoto H; Hirai K; Kawano M; Nishio M; Tsurudome M; O'Brien M; Komada H
    Drug Discov Ther; 2019; 13(6):314-321. PubMed ID: 31956229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legume lectins inhibit human parainfluenza virus type 2 infection by interfering with the entry.
    Uematsu J; Koyama A; Takano S; Ura Y; Tanemura M; Kihira S; Yamamoto H; Kawano M; Tsurudome M; O'Brien M; Komada H
    Viruses; 2012 Jul; 4(7):1104-15. PubMed ID: 22852043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin inhibits human parainfluenza virus type 2 replication in vitro.
    Kihira S; Uematsu J; Kawano M; Itoh A; Ookohchi A; Satoh S; Maeda Y; Sakai K; Yamamoto H; Tsurudome M; O'Brien M; Komada H
    Microbiol Immunol; 2014 Nov; 58(11):628-35. PubMed ID: 25154465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Kampo (traditional Japanese herbal) medicine, Hochuekkito, pretreatment in mice prevented influenza virus replication accompanied with GM-CSF expression and increase in several defensin mRNA levels.
    Dan K; Akiyoshi H; Munakata K; Hasegawa H; Watanabe K
    Pharmacology; 2013; 91(5-6):314-21. PubMed ID: 23796966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
    Shirayama R; Shoji M; Sriwilaijaroen N; Hiramatsu H; Suzuki Y; Kuzuhara T
    Drug Discov Ther; 2016; 10(2):109-13. PubMed ID: 26902927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of chemokine expression on intestinal epithelial cells by Kampo (traditional Japanese herbal) medicine, Hochuekkito, and its active ingredients.
    Sekiya M; Kiyohara H; Maruyama H; Yabe T; Yamada H
    J Nat Med; 2013 Jul; 67(3):626-35. PubMed ID: 23203627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.
    Schaap-Nutt A; Higgins C; Amaro-Carambot E; Nolan SM; D'Angelo C; Murphy BR; Collins PL; Schmidt AC
    J Virol; 2011 Apr; 85(8):4007-19. PubMed ID: 21289116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of 6-diazo-5-oxo-L-norleucine, antagonist of gamma-glutamyl transpeptidase, on replication of human parainfluenza virus type 2.
    Nishio M; Tsurudome M; Bando H; Komada H; Ito Y
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():61-7. PubMed ID: 1968085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete replication of human parainfluenza virus type 2 in mouse L929 cells.
    Ito Y; Tsurudome M; Bando H; Komada H; Nishio M
    Arch Virol; 1989; 108(1-2):137-44. PubMed ID: 2480761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan inhibits parainfluenza virus type 2 infection to LLCMK2 cells.
    Taoda N; Shinji E; Nishii K; Nishioka S; Yonezawa Y; Uematsu J; Hattori E; Yamamoto H; Kawano M; Tsurudome M; O'Brien M; Yamashita T; Komada H
    Biomed Res; 2008 Dec; 29(6):331-4. PubMed ID: 19129677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of shinbuto and ninjinto on prostaglandin E
    Ara T; Sogawa N
    PeerJ; 2017; 5():e4120. PubMed ID: 29209578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inosine pranobex - cytotoxic activities and effect of on replication of human parainfluenza viruses (HPIV-2, HPIV-4), entroviruses (CA16, EV71) and adenoviruses (HAdV-2, HAdV-5) in vitro].
    Majewska A; Lasek W; Młynarczyk G
    Med Dosw Mikrobiol; 2015; 67(2):107-13. PubMed ID: 26591662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete replication of human parainfluenza virus type 4 in LLC-MK2 cells and in L929 cells.
    Komada H; Inoue H; Yamabayashi C; Ito M; Kawano M; Nishio M; Tsurudome M; Kozuka Y; Noda N; Namba K; O'Brien M; Ito Y
    Med Microbiol Immunol; 2000 Jun; 188(4):185-9. PubMed ID: 10917155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.
    Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y
    J Virol; 2001 Oct; 75(19):9165-76. PubMed ID: 11533180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the antiallergic effects of kampo medicines used for the therapy of respiratory diseases.
    Nyunt AK; Takeuchi Y; Yokomuro K; Miyanaga Y
    Arerugi; 1995 Apr; 44(4):503-12. PubMed ID: 7598644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of stable free radicals from kampo medicines TJ-9, TJ-15, TJ-23, TJ-96, TJ-114 and their antioxidant effect on low density lipoproteins.
    Ondrias K; Stasko A; Gergel D; Hromadová M; Benes L
    Free Radic Res Commun; 1992; 16(4):227-37. PubMed ID: 1505783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system.
    Kiyohara H; Nagai T; Munakata K; Nonaka K; Hanawa T; Kim SJ; Yamada H
    Evid Based Complement Alternat Med; 2006 Dec; 3(4):459-67. PubMed ID: 17173109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.